FDA Approved: CAYSTON — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cayston (aztreonam) filed by Gilead Sciences, Inc., resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

SUPPL AP for CAYSTON (AZTREONAM)